In the last trading session, 120.0 million Salarius Pharmaceuticals Inc (NASDAQ:SLRX) shares changed hands as the company’s beta touched 0.82. With the company’s per share price at $3.67 changed hands at $2.1 or 134.50% during last session, the market valuation stood at $5.30M. SLRX’s last price was a discount, traded about -96.19% off its 52-week high of $7.20. The share price had its 52-week low at $1.22, which suggests the last value was 66.76% up since then. When we look at Salarius Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.11 million shares, with the 3-month average coming to 346.99K.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information

Instantly SLRX was in green as seen at the end of in last trading. With action 115.88%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 99.46%, with the 5-day performance at 115.88% in the green. However, in the 30-day time frame, Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is 126.54% up. Looking at the short shares, we see there were 65040.0 shares sold at short interest cover period of 0.08 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 64.97%.

SLRX Dividends

Salarius Pharmaceuticals Inc is expected to release its next quarterly earnings report in February.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.52% of Salarius Pharmaceuticals Inc shares while 0.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.37%.